Skip to main content
. 2022 Jul 11;22(9):330–333. doi: 10.1016/j.bjae.2022.04.001

Figure 2.

Figure 2

Management of chimeric antigen receptor T-cell-related neurotoxicity. Adapted from Société française de greffe de moelle et de thérapie cellulaire recommendations.11 CRS, cytokine release syndrome; ICANS, immune effector cell-associated neurotoxicity syndrome; ICE, immune effector cell-associated encephalopathy; LP, lumbar puncture.